This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage

Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage

15 May 2023

Third clinical molecule from collaboration with Sumitomo Pharma to enter Phase 1 trials DSP-2342, a dual 5-HT2A/5-HT7 antagonist to be assessed in psychiatric disease OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced that Sumitomo Pharma Co., Ltd. (‘Sumitomo Pharma’) plans to initiate a Phase 1 clinical study of DSP-2342 in the United States. DSP-2342 is a highly-selective bispecific small molecule with... Read more

OrganOx Chief Medical Officer, Professor Peter Friend, Elected as Vice President of Royal College of Surgeons of England

OrganOx Chief Medical Officer, Professor Peter Friend, Elected as Vice President of Royal College of Surgeons of England

12 May 2023

Oxford, United Kingdom, 12 May 2023: OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with metra®, a fully automated normothermic machine perfusion (NMP) device for liver transplantation, today announces that Chief Medical Officer, Professor Peter Friend, has been elected as Vice President of the Royal College of Surgeons of England. Professor Friend, a... Read more

Professor Andrew L. Hopkins elected Fellow of the Royal Society

Professor Andrew L. Hopkins elected Fellow of the Royal Society

10 May 2023

Professor Andrew L. Hopkins elected Fellow of the Royal Society May 10, 2023 Changing the world through exceptional science and technology OXFORD, England--(BUSINESS WIRE)-- Professor Andrew Hopkins DPhil LLD FRSE, founder and Chief Executive of Exscientia plc (Nasdaq: EXAI), has been elected a Fellow of the Royal Society, the world’s oldest and most influential scientific society. Andrew is one of the UK’s most eminent science and... Read more

OXBA Shortlisted Finalists Announced

OXBA Shortlisted Finalists Announced

03 May 2023

Judging for the 2023 Oxfordshire Business Awards is complete, and a shortlist of 32 businesses from across Oxfordshire can now be announced. Finalists have been announced across the 12 Award categories, including Purposeful Business, Marketing Excellence, New, Small and Large Business. All of the finalists will be in for the chance of winning the overall Business of the Year Award which this year, is sponsored by Thomas Franks. Since the... Read more

Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

03 May 2023

— Renowned thought leader in computational biology and data science for cancer research — — Over 180 publications on the evolutionary dynamics of cancer initiation, progression, response to therapy and emergence of resistance — OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors. Prof. Michor is a professor of Computational Biology... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More